These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


446 related items for PubMed ID: 21670771

  • 1. Elevated levels of neutrophil gelatinase-associated lipocalin in bile from patients with malignant pancreatobiliary disease.
    Zabron AA, Horneffer-van der Sluis VM, Wadsworth CA, Laird F, Gierula M, Thillainayagam AV, Vlavianos P, Westaby D, Taylor-Robinson SD, Edwards RJ, Khan SA.
    Am J Gastroenterol; 2011 Sep; 106(9):1711-7. PubMed ID: 21670771
    [Abstract] [Full Text] [Related]

  • 2. Differentiation of pancreatobiliary cancer from benign biliary strictures using neutrophil gelatinase-associated lipocalin.
    Budzynska A, Nowakowska-Dulawa E, Marek T, Boldys H, Nowak A, Hartleb M.
    J Physiol Pharmacol; 2013 Feb; 64(1):109-14. PubMed ID: 23568978
    [Abstract] [Full Text] [Related]

  • 3. Bile carcinoembryonic cell adhesion molecule 6 (CEAM6) as a biomarker of malignant biliary stenoses.
    Farina A, Dumonceau JM, Antinori P, Annessi-Ramseyer I, Frossard JL, Hochstrasser DF, Delhaye M, Lescuyer P.
    Biochim Biophys Acta; 2014 May; 1844(5):1018-25. PubMed ID: 23806607
    [Abstract] [Full Text] [Related]

  • 4. Neutrophil Gelatinase-Associated Lipocalin (NGAL) concentration in urine is superior to CA19-9 and Ca 125 in differentiation of pancreatic mass: Preliminary report.
    Hogendorf P, Durczyński A, Skulimowski A, Kumor A, Poznańska G, Strzelczyk J.
    Cancer Biomark; 2016 Mar 11; 16(4):537-43. PubMed ID: 27002756
    [Abstract] [Full Text] [Related]

  • 5. Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions.
    Ince AT, Yıldız K, Baysal B, Danalıoğlu A, Kocaman O, Tozlu M, Gangarapu V, Sarbay Kemik A, Uysal Ö, Şentürk H.
    Turk J Gastroenterol; 2014 Apr 11; 25(2):162-9. PubMed ID: 25003676
    [Abstract] [Full Text] [Related]

  • 6. Neutrophil gelatinase-associated lipocalin (NGAL) immunohistochemical expression in follicular cell-derived thyroid tumors: a novel diagnostic tool?
    Barresi V, Leni A, Tuccari G, Barresi G.
    Histol Histopathol; 2012 Mar 11; 27(3):329-36. PubMed ID: 22237710
    [Abstract] [Full Text] [Related]

  • 7. Expressions of neutrophil gelatinase-associated lipocalin in gastric cancer: a potential biomarker for prognosis and an ancillary diagnostic test.
    Wang HJ, He XJ, Ma YY, Jiang XT, Xia YJ, Ye ZY, Zhao ZS, Tao HQ.
    Anat Rec (Hoboken); 2010 Nov 11; 293(11):1855-63. PubMed ID: 20730863
    [Abstract] [Full Text] [Related]

  • 8. Neutrophil gelatinase-associated lipocalin, macrophage inhibitory cytokine 1, and carbohydrate antigen 19-9 in pancreatic juice: pathobiologic implications in diagnosing benign and malignant disease of the pancreas.
    Kaur S, Baine MJ, Guha S, Ochi N, Chakraborty S, Mallya K, Thomas C, Crook J, Wallace MB, Woodward TA, Jain M, Singh S, Sasson AR, Skinner V, Raimondo M, Batra SK.
    Pancreas; 2013 Apr 11; 42(3):494-501. PubMed ID: 23146921
    [Abstract] [Full Text] [Related]

  • 9. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia.
    Moniaux N, Chakraborty S, Yalniz M, Gonzalez J, Shostrom VK, Standop J, Lele SM, Ouellette M, Pour PM, Sasson AR, Brand RE, Hollingsworth MA, Jain M, Batra SK.
    Br J Cancer; 2008 May 06; 98(9):1540-7. PubMed ID: 18392050
    [Abstract] [Full Text] [Related]

  • 10. [Fecal neutrophil gelatinase-associated lipocalin is a surrogate marker of inflammation in inflammatory bowel disease].
    Zinkevich OD, Mukhametova DD, Abdulganieva DI, Safina NA, Koporulina MO, Odintsova AKh.
    Eksp Klin Gastroenterol; 2014 May 06; (10):22-7. PubMed ID: 25911926
    [Abstract] [Full Text] [Related]

  • 11. NGAL is an early predictive biomarker of contrast-induced nephropathy in children.
    Hirsch R, Dent C, Pfriem H, Allen J, Beekman RH, Ma Q, Dastrala S, Bennett M, Mitsnefes M, Devarajan P.
    Pediatr Nephrol; 2007 Dec 06; 22(12):2089-95. PubMed ID: 17874137
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
    Xue W, Xie Y, Wang Q, Xu W, Mou S, Ni Z.
    Nephrology (Carlton); 2014 Apr 06; 19(4):186-94. PubMed ID: 24165570
    [Abstract] [Full Text] [Related]

  • 13. CA19-9 antigen levels can distinguish between benign and malignant pancreaticobiliary disease.
    Morris-Stiff G, Teli M, Jardine N, Puntis MC.
    Hepatobiliary Pancreat Dis Int; 2009 Dec 06; 8(6):620-6. PubMed ID: 20007080
    [Abstract] [Full Text] [Related]

  • 14. Clinical value of circulating lipocalins and insulin-like growth factor axis in pancreatic cancer diagnosis.
    El-Mesallamy HO, Hamdy NM, Zaghloul AS, Sallam AM.
    Pancreas; 2013 Jan 06; 42(1):149-54. PubMed ID: 22617715
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Urinary neutrophil gelatinase-associated lipocalin accurately detects acute allograft rejection among other causes of acute kidney injury in renal allograft recipients.
    Heyne N, Kemmner S, Schneider C, Nadalin S, Königsrainer A, Häring HU.
    Transplantation; 2012 Jun 27; 93(12):1252-7. PubMed ID: 22513480
    [Abstract] [Full Text] [Related]

  • 17. Urinary neutrophil gelatinase-associated lipocalin as an early predictor of disease severity and mortality in acute pancreatitis.
    Lipinski M, Rydzewska-Rosolowska A, Rydzewski A, Rydzewska G.
    Pancreas; 2015 Apr 27; 44(3):448-52. PubMed ID: 25426620
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diagnostic value of neutrophil gelatinase-associated lipocalin (NGAL) immunoexpression in follicular-patterned lesions of the thyroid gland.
    Barresi V, Vitarelli E, Reggiani Bonetti L, Tuccari G, Barresi G.
    Virchows Arch; 2012 Mar 27; 460(3):319-25. PubMed ID: 22371224
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.